The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.

导出 LinkOut

翻译打印收藏纠错

作者： Krithika,Rajagopalan ^[1] ; Elizabeth Dansie,Bacci ^[2] ; Kathleen W,Wyrwich ^[3] ; Andrei,Pikalov ^[4] ; Antony,Loebel ^[5]

作者单位： Sunovion Pharmaceuticals Inc., Marlborough, MA, USA. krithika.rajagopalan@sunovion.com. ^[1] Evidera, 1417 Fourth Avenue, Suite 510, Seattle, WA, 98101, USA. elizabeth.bacci@evidera.com. ^[2] Evidera, Bethesda, MD, USA. kathy.wyrwich@evidera.com. ^[3] Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA. andrei.pikalov@sunovion.com. ^[4] Sunovion Pharmaceuticals Inc., Fort Lee, NJ, USA. antony.leobel@sunovion.com. ^[5]

关键词 Bipolar disorder Depression Patient functioning Sheehan disability scale

DOI 10.1186/s40345-016-0049-1

PMID 26928122

发布时间 2020-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览49

International journal of bipolar disorders

2016年4卷1期

7页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.

International journal of bipolar disorders

相似文献

International journal of bipolar disorders

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The direct and indirect effects of lurasidone monotherapy on functional improvement among patients with bipolar depression: results from a randomized placebo-controlled trial.

International journal of bipolar disorders

相似文献

International journal of bipolar disorders

相关期刊

检索历史清除